VistaCare by DTAMedical
André Fond has a diverse work experience across various companies and roles. andre started at HOSPAL in 1989 as the Head of Electronic & Computing Department and later became the International Product Manager. In 1996, they joined GAMBRO as the International Marketing Manager. In 2002, they became the CTO at Efiscience before moving on to NéliXa in 2003 as a Business Developer. At NéliXa, they supported the development of innovative products in the biomedical and information technology fields. In 2006, André became the CEO of VISOOON, where they led the company's software programs and research and development projects. In 2012, they became the Project Leader at SKINAN Project, and in 2014, they joined VistaCare by DTAMedical as the R&D and QA/RA Manager. Currently, André is the General Manager at ANAPIX medical since 2016.
André Fond completed their PhD in Biomedical from Université de Technologie de Compiègne (UTC) from 1980 to 1984. andre later pursued a Master of Business Administration (MBA) from emlyon business school, graduating in the year 2000. No specific field of study is mentioned for their MBA.
This person is not in any teams
VistaCare by DTAMedical
DTAMedical develops, manufactures and distributes medical devices for the treatment of the critical phase of wounds, whether acute or chronic. We contribute with health professionals to improve the lives of patients suffering from complex wounds that are difficult to treat with standard therapies. Our WEC* concept, using the VistaCare technology, aims to provide an innovative solution, based on natural physiology, by controlling the wound environment, and providing the caregivers with tools adapted to each stage of the wound healing process. The proposed technique, through WEC Therapy, is unique and patented. *WEC : Wound Environment Controlled